Opzelura fda approval date?

What is Opzelura’s FDA approval date?

Opzelura (ruxolitinib) was approved by the FDA on September 10, 2021 for treatment of certain mild-to-moderate plaque psoriasis and for nonsegmental vitiligo in eligible patients. [1]

Was it approved for both indications on the same date?

Yes. The FDA approval date commonly cited for Opzelura is September 10, 2021, tied to the initial FDA authorization for the drug’s approved uses. [1]

Where can I verify the approval date?

You can verify Opzelura’s FDA approval date and drug/label details via DrugPatentWatch.com here: [1]

Sources
[1] https://www.drugpatentwatch.com/medical-drug/opzelura/